Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 2
2020 6
2021 3
2022 7
2023 7
2024 6
2025 12
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
The Use of Cannabidiol in Metabolic Syndrome-An Opportunity to Improve the Patient's Health or Much Ado about Nothing?
Wiciński M, Fajkiel-Madajczyk A, Kurant Z, Gryczka K, Kurant D, Szambelan M, Malinowski B, Falkowski M, Zabrzyński J, Słupski M. Wiciński M, et al. J Clin Med. 2023 Jul 11;12(14):4620. doi: 10.3390/jcm12144620. J Clin Med. 2023. PMID: 37510734 Free PMC article. Review.
We summarised the most recent research on the broad topic of cannabis-derived influence on metabolic syndrome components. Since there is a lot of work on the effects of delta9-THC (delta9-tetrahydrocannabinol) on metabolism and far less on cannabidiol, we fel …
We summarised the most recent research on the broad topic of cannabis-derived influence on metabolic syndrome components. Sinc …
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
Botticelli L, Micioni Di Bonaventura E, Einaudi G, Provensi G, Costa A, D'Addario C, Cifani C, Micioni Di Bonaventura MV. Botticelli L, et al. Br J Pharmacol. 2025 Sep 27. doi: 10.1111/bph.70196. Online ahead of print. Br J Pharmacol. 2025. PMID: 41014043 Review.
The aim of this review is to describe the potential role of CBD in the control of food intake and metabolism, with implications for the treatment of obesity and metabolic syndrome, and to discuss the underlying potential mechanisms of action. The preclinical evidenc …
The aim of this review is to describe the potential role of CBD in the control of food intake and metabolism, with implications for the trea …
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470 Free article. Review.
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. Although there has been much speculation about the therapeutic value of cannabi …
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is r …
Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation.
El-Hammadi MM, Martín-Navarro L, Berrocoso E, Álvarez-Fuentes J, Crespo-Facorro B, Suárez-Pereira I, Vázquez-Bourgon J, Martín-Banderas L. El-Hammadi MM, et al. J Biomed Mater Res A. 2025 May;113(5):e37916. doi: 10.1002/jbm.a.37916. J Biomed Mater Res A. 2025. PMID: 40277882
Cannabidiol (CBD) holds promise for managing metabolic diseases, yet enhancing its oral bioavailability and efficacy remains challenging. ...Their therapeutic potential was evaluated in an in vitro metabolic syndrome model employing sodium palmitate-in …
Cannabidiol (CBD) holds promise for managing metabolic diseases, yet enhancing its oral bioavailability and efficacy remains c …
[The potential use of cannabidiol in the therapy of metabolic syndrome].
Kleiner D, Ditrói K. Kleiner D, et al. Orv Hetil. 2012 Apr 1;153(13):499-504. doi: 10.1556/OH.2012.29308. Orv Hetil. 2012. PMID: 22430005 Review. Hungarian.
Cannabidiol, a cannabinoid and serotonin receptor antagonist, may alleviate hyperphagia without the side effects of rimonabant (for example depression and reduced insulin sensitivity). ...It may also be effective in fighting ischaemic diseases, the most harmful complicatio …
Cannabidiol, a cannabinoid and serotonin receptor antagonist, may alleviate hyperphagia without the side effects of rimonabant (for e …
Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome.
Ponce-Díaz FJ, Ruiz-Pino F, Garrido-Rodriguez M, Prados-González ME, Uceda-Rodriguez E, Cerero-Tejero L, Guerrero-Ruiz Y, Sanchez-Garrido MA, Muñoz E, Tena-Sempere M. Ponce-Díaz FJ, et al. Diabetes Obes Metab. 2025 Oct;27(10):6027-6031. doi: 10.1111/dom.16602. Epub 2025 Jul 9. Diabetes Obes Metab. 2025. PMID: 40635171 Free PMC article. No abstract available.
Anorexia and the Cancer Patient.
Johannes CM, Musser ML. Johannes CM, et al. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):837-854. doi: 10.1016/j.cvsm.2019.04.008. Epub 2019 Jun 6. Vet Clin North Am Small Anim Pract. 2019. PMID: 31176457 Review.
Inappetence often is multifactorial, complicating treatment. Cancer-related anorexia/cachexia syndrome is a metabolic, paraneoplastic syndrome characterized by decreased food intake, involuntary weight loss, and loss of fat and muscle. ...
Inappetence often is multifactorial, complicating treatment. Cancer-related anorexia/cachexia syndrome is a metabolic, paraneo …
Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS, Mahajan UB, Agrawal YO, Patil KR, Patil CR, Ojha S, Sharma C, Goyal SN. Patil AS, et al. Biomed Pharmacother. 2020 Dec;132:110889. doi: 10.1016/j.biopha.2020.110889. Epub 2020 Oct 28. Biomed Pharmacother. 2020. PMID: 33113429 Free article. Review.
In the present article, we reviewed the role of natural cannabinoid compounds in metabolic disorders and related complications. We studied variety of a plant-derived cannabinoids in treating the metabolic syndrome including stoutness, fatty acid liver disease …
In the present article, we reviewed the role of natural cannabinoid compounds in metabolic disorders and related complications. We st …
Dietary cannabidiol oil mitigates metabolic dysfunction in mice with high-fat diet-induced obesity.
Bravo Iniguez A, Sun Q, Tian Q, Du M, Zhu MJ. Bravo Iniguez A, et al. J Nutr Biochem. 2025 Dec;146:110040. doi: 10.1016/j.jnutbio.2025.110040. Epub 2025 Jul 23. J Nutr Biochem. 2025. PMID: 40712842 Free article.
Metabolic syndrome (MetS) is a widespread health concern driven largely by lifestyle behaviors such as dietary choices and physical inactivity. Excessive caloric intake promotes adiposity and dysregulation of metabolic signaling in adipose tissue. This study …
Metabolic syndrome (MetS) is a widespread health concern driven largely by lifestyle behaviors such as dietary choices and phy …
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome.
Salles ÉL, Khodadadi H, Jarrahi A, Ahluwalia M, Paffaro VA Jr, Costigliola V, Yu JC, Hess DC, Dhandapani KM, Baban B. Salles ÉL, et al. J Cell Mol Med. 2020 Nov;24(21):12869-12872. doi: 10.1111/jcmm.15883. Epub 2020 Oct 15. J Cell Mol Med. 2020. PMID: 33058425 Free PMC article.
In a follow-up study to our recent findings indicating the potential of Cannabidiol (CBD) in the treatment of acute respiratory distress syndrome (ARDS), here we show for the first time that CBD may ameliorate the symptoms of ARDS through up-regulation of apelin, a …
In a follow-up study to our recent findings indicating the potential of Cannabidiol (CBD) in the treatment of acute respiratory distr …
57 results